2-(benzo[d]thiazol-5-yl)-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,3]diazepine-3-carboxamide

ID: ALA4535795

PubChem CID: 155548006

Max Phase: Preclinical

Molecular Formula: C15H15N5OS

Molecular Weight: 313.39

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCCC2

Standard InChI:  InChI=1S/C15H15N5OS/c16-14(21)12-13(19-20-6-2-1-5-17-15(12)20)9-3-4-11-10(7-9)18-8-22-11/h3-4,7-8,17H,1-2,5-6H2,(H2,16,21)

Standard InChI Key:  GBGIZMVLABTYKN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 25  0  0  0  0  0  0  0  0999 V2000
   23.8713  -14.4947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6226  -13.7136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8063  -13.7120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3293  -13.0484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6655  -12.3036    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5162  -13.1297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.1011  -13.0579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9144  -13.1480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2509  -11.6543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7718  -12.3136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0693  -11.7321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3955  -12.4877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2121  -12.4071    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.3890  -11.6057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6818  -11.1887    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   22.5515  -14.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2077  -14.9671    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2475  -15.7837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7641  -14.7082    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6391  -16.3226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4441  -15.4604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8377  -16.1765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 17  1  1  0
  1  2  2  0
  2  3  1  0
  3 16  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  7  8  2  0
  8 12  1  0
 11  9  1  0
  9 10  2  0
 10  7  1  0
  2  7  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
 21 22  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4535795

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 313.39

Molecular Weight (Monoisotopic): 313.0997

AlogP: 2.46

#Rotatable Bonds: 2

Polar Surface Area: 85.83

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.82

CX Basic pKa: 2.74

CX LogP: 2.04

CX LogD: 2.04

Aromatic Rings: 3

Heavy Atoms: 22

QED Weighted: 0.76

Np Likeness Score: -1.49

References

1. Haffner CD, Charnley AK, Aquino CJ, Casillas L, Convery MA, Cox JA, Elban MA, Goodwin NC, Gough PJ, Haile PA, Hughes TV, Knapp-Reed B, Kreatsoulas C, Lakdawala AS, Li H, Lian Y, Lipshutz D, Mehlmann JF, Ouellette M, Romano J, Shewchuk L, Shu A, Votta BJ, Zhou H, Bertin J, Marquis RW..  (2019)  Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors.,  10  (11): [PMID:31749904] [10.1021/acsmedchemlett.9b00141]

Source

Source(1):

• Scientific Literature